On the path to conquering cancer
Novogen uses a virtual model in its approach to drug discovery and development. The new lean corporate structure focuses on its human capital in-place of expensive facilities and equipment that can be outsourced. The drug discovery strategies and plans are created in-house then executed by a number of leading external research organizations. This affords Novogen immediate access to cutting edge facilities, skills, equipment and scale-up processes. This strategy drives efficiencies over the drug discovery/development continuum.
Novogen has generated a series of strategic relationships with a number of organizations to create our new pipeline of oncology products. The Novogen executive team has extensive experience in the management and monitoring of external Contract Research Organizations (CRO’s) focused on drug discovery and drug development.